Seriously, the data in the press release this morning from their abstract at AAIC 2021 suggests Bryostatin worked in both Phase 2 trials upon further analysis. The relevance is they show improvements in cognition for advanced Alzheimer’s patients versus placebo. This is truly a miracle and will be well received by the doctors at the conference and pre…
© 2024 Fein Luxe LLC
Substack is the home for great culture